Nitroimidazole radiosensitizers for hypoxic tumor cells and comp

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424273R, 546210, 548336, A61K 31415, A61K 31445, C07D40106, C07D40306

Patent

active

042822327

ABSTRACT:
Biologically active hypoxic cell radiosensitizers of the formula ##STR1## wherein Z is a C.sub.2 -C.sub.4 alkylene group which may be substituted by OH; wherein R.sup.1 and R.sup.2 are same or different substituted or unsubstituted C.sub.1 -C.sub.4 alkyl groups, or R.sup.1 and R.sup.2 taken together with the nitrogen atom form a heterocyclic ring of the formula ##STR2## wherein n=0 or 1, with the condition that when n=0, m=2 or 3 and when n=1, m=1 or 2;

REFERENCES:
patent: 3646057 (1972-02-01), Beaman et al.
Agrawal et al., "Abstract from the Joint Meeting of ASPET/SOT," Houston, TX, Aug. 13 to 17, 1978.
Beaman et al., "Antimicrobial Agents and Chemotherapy", p. 520, (1967).
Adams, "Chemotherapy", vol. 7, (1976), pp. 187-204.
Sheldon et al., "British Journal of Cancer", (1977) 35, p. 795.
Andrews, The Radiobiology of Human Cancer Radiotherapy, 2nd ed., (1978), University Park Press, pp. 471-505.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Nitroimidazole radiosensitizers for hypoxic tumor cells and comp does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nitroimidazole radiosensitizers for hypoxic tumor cells and comp, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nitroimidazole radiosensitizers for hypoxic tumor cells and comp will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-240282

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.